These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29898682)

  • 1. Patient care activities by community pharmacists in a capitation funding model mental health and addictions program.
    Murphy AL; Gardner DM; Jacobs LM
    BMC Psychiatry; 2018 Jun; 18(1):192. PubMed ID: 29898682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of patient care activities in a community pharmacy mental illness and addictions program.
    Haslam L; Gardner DM; Murphy AL
    Res Social Adm Pharm; 2020 Apr; 16(4):522-528. PubMed ID: 31327736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
    Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
    BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacists' experiences in mental illness and addictions care: a qualitative study.
    Murphy AL; Phelan H; Haslam S; Martin-Misener R; Kutcher SP; Gardner DM
    Subst Abuse Treat Prev Policy; 2016 Jan; 11():6. PubMed ID: 26821700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
    Papastergiou J; Tolios P; Li W; Li J
    J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoption of the Nova Scotia (Canada) Community Pharmacy Medication Management Program, 1-Year Post-Initiation.
    Deal HJ; Cooke CA; Ingram EM; Sketris IS
    J Popul Ther Clin Pharmacol; 2017 Feb; 24(1):e46-e55. PubMed ID: 28186715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Med Wise: A theory-based program to improve older adults' communication with pharmacists about their medicines.
    Martin BA; Chewning BA; Margolis AR; Wilson DA; Renken J
    Res Social Adm Pharm; 2016; 12(4):569-77. PubMed ID: 26508269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing a pharmacist-led in-home medication coaching service via community-based partnerships.
    Akers JL; Meer G; Kintner J; Shields A; Dillon-Sumner L; Bacci JL
    J Am Pharm Assoc (2003); 2019; 59(2):243-251. PubMed ID: 30638730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
    Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
    J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider perceptions of pharmacists providing mental health medication support in patient-centered medical homes.
    Coe AB; Bostwick JR; Choe HM; Thompson AN
    J Am Pharm Assoc (2003); 2019; 59(4):555-559. PubMed ID: 31010786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.
    Boyle TA; Bishop AC; Duggan K; Reid C; Mahaffey T; MacKinnon NJ; Mahaffey A
    Res Social Adm Pharm; 2014; 10(1):45-57. PubMed ID: 23528447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New roles for pharmacists in community mental health care: a narrative review.
    Rubio-Valera M; Chen TF; O'Reilly CL
    Int J Environ Res Public Health; 2014 Oct; 11(10):10967-90. PubMed ID: 25337943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
    Bradley CL; Luder HR; Beck AF; Bowen R; Heaton PC; Kahn RS; Mansour M; Obszarski S; Frede SM
    J Am Pharm Assoc (2003); 2016; 56(4):455-60. PubMed ID: 27245855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A roadmap beyond dispensing for educating and training community pharmacists on key mental health competencies: A mixed-methods national study.
    Alzubaidi H; Saidawi W; Goldstone L; Saddik B; Abduelkarem AR; Abu-Gharbieh E; Alzoubi KH; Samorinha C
    Res Social Adm Pharm; 2024 Jun; 20(6):134-145. PubMed ID: 38503576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' performance in a telephone-based simulated patient study after a mental health capacity-building program.
    Murphy AL; Martin-Misener R; Kutcher SP; Gardner DM
    Int J Clin Pharm; 2015 Dec; 37(6):1009-13. PubMed ID: 26210258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.